Apnimed, Inc. (APMD) stock
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)
Close on Nov 17, 2026Market cap $85.47MP/E –Yield –
Apnimed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.08M | – |
| Q2 FY2025 | Jun 30, 2025 | $17.11M | – |
See a number that looks wrong?